Literature DB >> 7315914

Placental clearance rate of maternal plasma androstenedione through placental estradiol formation: an indirect method of assessing uteroplacental blood flow.

C D Edman, A Toofanian, P C MacDonald, N F Gant.   

Abstract

The metabolism of androstenedione (A) by the placenta in late pregnancy and the early puerperium was studied. The metabolic clearance rate of A (MCR-A) was increased in pregnant women, 2,825 +/- 207 L/24 hr (mean +/- SEM), compared to 2,020 +/- 140 L/24 hr in nonpregnant women of similar body weight. The immediate puerperal MCR-A was 2,538 +/- 50 L/24 hr. Therefore, approximately 10% of maternal plasma A was cleared by the placenta. In the latter half of pregnancy, the extent of conversion of maternal plasma A through estradiol formation, (rho)AE2, was increased, whereas in the immediate puerperium it was normal, 0.018. Moreover, 90% of aromatase activity was attributed to the placenta in late pregnancy. From these data, we computed that the placental clearance rate of A through estradiol (PCAE2) from whole blood was 497 +/- 41 ml/min in women with a single fetus and 691 +/- 102 ml/min in women with twin fetuses. Thus, it appears that the PCAE2 is a sensitive index of maternal-placental perfusion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315914     DOI: 10.1016/s0002-9378(16)32694-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Maternal uterine vascular remodeling during pregnancy.

Authors:  George Osol; Maurizio Mandala
Journal:  Physiology (Bethesda)       Date:  2009-02

2.  Ovarian and adrenal androgens and their link to high human chorionic gonadotropin levels: a prospective controlled study.

Authors:  René Rodríguez-Gutiérrez; Jesús Zacarías Villarreal-Pérez; Felipe Arturo Morales-Martinez; René Rodríguez-Guajardo; Gloria González-Saldivar; Leonardo G Mancillas-Adame; Neri Alejandro Alvarez-Villalobos; Fernando Javier Lavalle-Gonzalez; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2014-11-23       Impact factor: 3.257

3.  Umbilical cord blood androgen levels and ASD-related phenotypes at 12 and 36 months in an enriched risk cohort study.

Authors:  Bo Y Park; Brian K Lee; Igor Burstyn; Loni P Tabb; Jeff A Keelan; Andrew J O Whitehouse; Lisa A Croen; Margaret D Fallin; Irva Hertz-Picciotto; Owen Montgomery; Craig J Newschaffer
Journal:  Mol Autism       Date:  2017-01-31       Impact factor: 7.509

4.  Hypertensive disorders during pregnancy and polycystic ovary syndrome are associated with child communication and social skills in a sex-specific and androgen-dependent manner.

Authors:  Morgan R Firestein; Russell D Romeo; Hailey Winstead; Danielle A Goldman; William A Grobman; David M Haas; Samuel Parry; Uma M Reddy; Robert M Silver; Ronald J Wapner; Frances A Champagne
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

5.  Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.

Authors:  Paula S Lee; Samantha Kempner; Michael Miller; Jennifer Dominguez; Chad Grotegut; Jessie Ehrisman; Rebecca Previs; Laura J Havrilesky; Gloria Broadwater; Sarah C Ellestad; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2017-08-22

Review 6.  Androgens in pregnancy: roles in parturition.

Authors:  Sofia Makieva; Philippa T K Saunders; Jane E Norman
Journal:  Hum Reprod Update       Date:  2014-03-18       Impact factor: 15.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.